Ewing’s U: Dr. Chandrika Behura NEW Clinical Trial | Ck2 Inhibitor for Solid Tumors

Ewing's U
Written By Alana Arens

In this episode of Ewing’s U, Dr. Chandrika Behura (at Penn State Health Children's Hospital) discusses the research behind a new CK2 inhibitor for solid tumors (including Ewing sarcoma) and shares details about a new clinical trial (BCC021) through the Beat Childhood Cancer Research Consortium.

Alana Arens
Previous

Ewing's U: NK Cell Therapy for Ewing sarcoma
Next

Ewing’s U: Dr. Matthew Ladra: Proton Radiation Therapy for Pediatric Sarcomas